Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools
- PMID: 8254768
- PMCID: PMC236318
- DOI: 10.1128/JVI.68.1.535-540.1994
Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools
Abstract
Human immunodeficiency virus type 1 (HIV-1) replication is shown to be sensitive to the intracellular concentration of deoxynucleoside triphosphate substrates. Addition of thymidine to established cell lines resulted in a dramatic reduction of virus production. The effect could be substantially alleviated by addition of deoxycytidine, which, alone, enhanced viral titers by a factor of 2 to 3. Hydroxyurea treatment abolished HIV-1 replication in peripheral blood mononuclear cells and could be reversed by deoxyadenosine. These data show that HIV-1 replication occurs under suboptimal DNA precursor conditions.
Similar articles
-
Changes of deoxyribonucleoside triphosphate pools induced by hydroxyurea and their relation to DNA synthesis.J Biol Chem. 1986 Dec 5;261(34):16037-42. J Biol Chem. 1986. PMID: 3536919
-
Effects of X-irradiation on DNA precursor metabolism and deoxyribonucleoside triphosphate pools in Chinese hamster cells.Radiat Res. 1974 Oct;60(1):173-201. Radiat Res. 1974. PMID: 10881709 No abstract available.
-
HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.Nature. 2011 Nov 6;480(7377):379-82. doi: 10.1038/nature10623. Nature. 2011. PMID: 22056990
-
A kinetic model of regulation of the deoxyribonucleoside triphosphate pool composition.Pharmacol Ther. 1984;24(2):279-301. doi: 10.1016/0163-7258(84)90038-x. Pharmacol Ther. 1984. PMID: 6379685 Review. No abstract available.
-
Changes in deoxynucleoside triphosphate pools induced by inhibitors and modulators of ribonucleotide reductase.Pharmacol Ther. 1985;30(1):31-42. doi: 10.1016/0163-7258(85)90046-4. Pharmacol Ther. 1985. PMID: 3915820 Review.
Cited by
-
Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication.Mol Med. 2012 Sep 25;18(1):1096-108. doi: 10.2119/molmed.2012.00194. Mol Med. 2012. PMID: 22692576 Free PMC article. Review.
-
Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs.Nat Rev Microbiol. 2009 Nov;7(11):798-812. doi: 10.1038/nrmicro2223. Nat Rev Microbiol. 2009. PMID: 19834480 Review.
-
3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1.J Virol. 2000 Oct;74(20):9532-9. doi: 10.1128/jvi.74.20.9532-9539.2000. J Virol. 2000. PMID: 11000223 Free PMC article.
-
Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.J Virol. 1996 Feb;70(2):1271-6. doi: 10.1128/JVI.70.2.1271-1276.1996. J Virol. 1996. PMID: 8551594 Free PMC article.
-
Deficient uracil base excision repair leads to persistent dUMP in HIV proviruses during infection of monocytes and macrophages.PLoS One. 2020 Jul 14;15(7):e0235012. doi: 10.1371/journal.pone.0235012. eCollection 2020. PLoS One. 2020. PMID: 32663205 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources